S&P 500: 669.47 +1.1% NASDAQ 100: 600.94 +1.2% Dow Jones: 470.70 +0.9%

Claritev Corporation

CTEV Healthcare
$17.8 +$0.91 (5.39%)
Market Cap: $294.64 M
Gurus Holding
5
Popularity Rank
#1832
% of Shares Held
1.90%
Net Activity (Q4 2025)
+$7.49 M

Guru Ownership Trend

Guru Analysis for Claritev Corporation (CTEV)

Claritev Corporation (CTEV), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.6 M.

Top institutional holders include Daniel Loeb and Renaissance Technologies.

Institutional sentiment is currently Bullish. This is evidenced by a $7.49 M net inflow during the quarter.

Recent activity highlights Steven Cohen who increased their stake by 324.7%. Conversely, Renaissance Technologies reduced exposure by 32.9%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$9.17 M
Total Buy Value
New Buys 2
Additions 2
-$1.67 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
1
Net Buyers
4

FAQs for Claritev Corporation (CTEV)

Major holders include Daniel Loeb ($6.2 M), Renaissance Technologies ($3.42 M), Steven Cohen ($2.92 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 314,349 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $7.49 M, with 4 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CTEV. The total reported sell value was $1.67 M.

Yes, 2 managers opened new positions in CTEV, and 2 increased their existing holdings. The total reported buy value was $9.17 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.09% New Buy 145,000 $6.2 M Q4 2025
0.01% Reduce -32.9% 79,915 $3.42 M Q4 2025
0.00% Add 324.7% 68,217 $2.92 M Q4 2025
0.00% Add 170.8% 10,717 $458,153 Q4 2025
0.11% New Buy 10,500 $448,875 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form